[English] 日本語
Yorodumi
- PDB-6p8h: Crystal structure of CDK4 in complex with CyclinD1 and P21 -

+
Open data


ID or keywords:

Loading...

-
Basic information

Entry
Database: PDB / ID: 6p8h
TitleCrystal structure of CDK4 in complex with CyclinD1 and P21
Components
  • Cyclin-dependent kinase 4
  • Cyclin-dependent kinase inhibitor 1
  • G1/S-specific cyclin-D1
Keywordscell cycle / transferase / Cyclin-dependent kinase / kinase inhibitor
Function / homology
Function and homology information


: / cellular response to cell-matrix adhesion / cyclin D3-CDK4 complex / cyclin D1-CDK4 complex / cyclin D2-CDK4 complex / Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 / Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 / negative regulation of cyclin-dependent protein kinase activity / negative regulation of cardiac muscle tissue regeneration / re-entry into mitotic cell cycle ...: / cellular response to cell-matrix adhesion / cyclin D3-CDK4 complex / cyclin D1-CDK4 complex / cyclin D2-CDK4 complex / Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 / Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 / negative regulation of cyclin-dependent protein kinase activity / negative regulation of cardiac muscle tissue regeneration / re-entry into mitotic cell cycle / cyclin D1-CDK6 complex / cellular response to ionomycin / regulation of transcription initiation by RNA polymerase II / Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 / Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 / Drug-mediated inhibition of CDK4/CDK6 activity / regulation of type B pancreatic cell proliferation / RUNX3 regulates WNT signaling / FOXO-mediated transcription of cell cycle genes / TFAP2 (AP-2) family regulates transcription of cell cycle factors / response to leptin / negative regulation of phosphorylation / positive regulation of mammary gland epithelial cell proliferation / intestinal epithelial cell maturation / tissue regeneration / PCNA-p21 complex / regulation of cell cycle G1/S phase transition / import into nucleus / Transcriptional regulation by RUNX2 / cellular response to phorbol 13-acetate 12-myristate / negative regulation of DNA biosynthetic process / cyclin-dependent protein serine/threonine kinase inhibitor activity / positive regulation of cyclin-dependent protein serine/threonine kinase activity / response to arsenic-containing substance / cyclin-dependent protein serine/threonine kinase activator activity / proline-rich region binding / oncogene-induced cell senescence / Transcriptional activation of cell cycle inhibitor p21 / Regulation of RUNX1 Expression and Activity / positive regulation of programmed cell death / AKT phosphorylates targets in the cytosol / RUNX3 regulates CDKN1A transcription / regulation of cyclin-dependent protein serine/threonine kinase activity / stress-induced premature senescence / cyclin-dependent protein serine/threonine kinase regulator activity / mammary gland epithelial cell proliferation / response to UV-A / response to corticosterone / molecular function inhibitor activity / cellular response to UV-B / negative regulation of epithelial cell differentiation / STAT5 activation downstream of FLT3 ITD mutants / negative regulation of G1/S transition of mitotic cell cycle / response to aldosterone / p53-Dependent G1 DNA Damage Response / protein kinase inhibitor activity / PTK6 Regulates Cell Cycle / Constitutive Signaling by AKT1 E17K in Cancer / fat cell differentiation / mitotic G2 DNA damage checkpoint signaling / negative regulation of vascular associated smooth muscle cell proliferation / Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) / microtubule organizing center / regulation of G1/S transition of mitotic cell cycle / Transcriptional Regulation by VENTX / RUNX3 regulates p14-ARF / keratinocyte proliferation / replicative senescence / mammary gland alveolus development / intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator / Estrogen-dependent nuclear events downstream of ESR-membrane signaling / response to X-ray / positive regulation of protein kinase activity / response to hyperoxia / bicellular tight junction / positive regulation of G1/S transition of mitotic cell cycle / cyclin-dependent kinase / animal organ regeneration / cyclin-dependent protein serine/threonine kinase activity / TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest / Regulation of MITF-M-dependent genes involved in cell cycle and proliferation / Cyclin E associated events during G1/S transition / endoplasmic reticulum unfolded protein response / Cyclin A:Cdk2-associated events at S phase entry / cyclin-dependent protein kinase holoenzyme complex / keratinocyte differentiation / regulation of G2/M transition of mitotic cell cycle / mitotic G1 DNA damage checkpoint signaling / protein serine/threonine kinase binding / positive regulation of G2/M transition of mitotic cell cycle / positive regulation of B cell proliferation / lactation / transcription repressor complex / Signaling by FLT3 fusion proteins / intrinsic apoptotic signaling pathway / cellular response to amino acid starvation / cellular response to interleukin-4 / protein sequestering activity / cyclin binding / molecular function activator activity
Similarity search - Function
Cyclin-dependent kinase inhibitor 1 / Cyclin-dependent kinase inhibitor domain / Cyclin-dependent kinase inhibitor domain superfamily / Cyclin-dependent kinase inhibitor / Cyclin, C-terminal domain / : / Cyclins signature. / Cyclin / Cyclin, C-terminal domain / Cyclin_C ...Cyclin-dependent kinase inhibitor 1 / Cyclin-dependent kinase inhibitor domain / Cyclin-dependent kinase inhibitor domain superfamily / Cyclin-dependent kinase inhibitor / Cyclin, C-terminal domain / : / Cyclins signature. / Cyclin / Cyclin, C-terminal domain / Cyclin_C / Cyclin-like / Cyclin A; domain 1 / Cyclin, N-terminal / Cyclin, N-terminal domain / Cyclin-like / domain present in cyclins, TFIIB and Retinoblastoma / Cyclin-like superfamily / : / Phosphorylase Kinase; domain 1 / Phosphorylase Kinase; domain 1 / Transferase(Phosphotransferase) domain 1 / Transferase(Phosphotransferase); domain 1 / Serine/threonine-protein kinase, active site / Serine/Threonine protein kinases active-site signature. / Protein kinase domain / Serine/Threonine protein kinases, catalytic domain / Protein kinase, ATP binding site / Protein kinases ATP-binding region signature. / Protein kinase domain profile. / Protein kinase domain / Protein kinase-like domain superfamily / 2-Layer Sandwich / Orthogonal Bundle / Mainly Alpha / Alpha Beta
Similarity search - Domain/homology
Cyclin-dependent kinase 4 / G1/S-specific cyclin-D1 / Cyclin-dependent kinase inhibitor 1
Similarity search - Component
Biological speciesHomo sapiens (human)
MethodX-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / Resolution: 3.19 Å
AuthorsGuiley, K.Z. / Stevenson, J.W. / Lou, K. / Barkovich, K.J. / Bunch, K. / Tripathi, S.M. / Shokat, K.M. / Rubin, S.M.
Funding support United States, 2items
OrganizationGrant numberCountry
National Institutes of Health/National Cancer Institute (NIH/NCI)GM124148 United States
National Institutes of Health/National Cancer Institute (NIH/NCI)CA206244 United States
CitationJournal: Science / Year: 2019
Title: p27 allosterically activates cyclin-dependent kinase 4 and antagonizes palbociclib inhibition.
Authors: Guiley, K.Z. / Stevenson, J.W. / Lou, K. / Barkovich, K.J. / Kumarasamy, V. / Wijeratne, T.U. / Bunch, K.L. / Tripathi, S. / Knudsen, E.S. / Witkiewicz, A.K. / Shokat, K.M. / Rubin, S.M.
History
DepositionJun 7, 2019Deposition site: RCSB / Processing site: RCSB
Revision 1.0Dec 25, 2019Provider: repository / Type: Initial release
Revision 1.1Oct 11, 2023Group: Data collection / Database references / Refinement description
Category: chem_comp_atom / chem_comp_bond ...chem_comp_atom / chem_comp_bond / database_2 / pdbx_initial_refinement_model
Item: _database_2.pdbx_DOI / _database_2.pdbx_database_accession

-
Structure visualization

Structure viewerMolecule:
MolmilJmol/JSmol

Downloads & links

-
Assembly

Deposited unit
A: G1/S-specific cyclin-D1
B: Cyclin-dependent kinase 4
C: Cyclin-dependent kinase inhibitor 1


Theoretical massNumber of molelcules
Total (without water)71,4803
Polymers71,4803
Non-polymers00
Water00
1


  • Idetical with deposited unit
  • defined by author&software
  • Evidence: gel filtration
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
Buried area5930 Å2
ΔGint-45 kcal/mol
Surface area25990 Å2
MethodPISA
Unit cell
Length a, b, c (Å)62.620, 67.980, 185.360
Angle α, β, γ (deg.)90.00, 90.00, 90.00
Int Tables number18
Space group name H-MP21221

-
Components

#1: Protein G1/S-specific cyclin-D1 / B-cell lymphoma 1 protein / BCL-1 / BCL-1 oncogene / PRAD1 oncogene


Mass: 28445.293 Da / Num. of mol.: 1
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Gene: CCND1, BCL1, PRAD1 / Production host: Spodoptera frugiperda (fall armyworm) / References: UniProt: P24385
#2: Protein Cyclin-dependent kinase 4 / Cell division protein kinase 4 / PSK-J3


Mass: 33947.930 Da / Num. of mol.: 1
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Gene: CDK4 / Production host: Spodoptera frugiperda (fall armyworm) / References: UniProt: P11802, cyclin-dependent kinase
#3: Protein Cyclin-dependent kinase inhibitor 1 / CDK-interacting protein 1 / Melanoma differentiation-associated protein 6 / MDA-6 / p21


Mass: 9087.271 Da / Num. of mol.: 1
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Gene: CDKN1A, CAP20, CDKN1, CIP1, MDA6, PIC1, SDI1, WAF1 / Production host: Spodoptera frugiperda (fall armyworm) / References: UniProt: P38936

-
Experimental details

-
Experiment

ExperimentMethod: X-RAY DIFFRACTION / Number of used crystals: 1

-
Sample preparation

CrystalDensity Matthews: 2.76 Å3/Da / Density % sol: 55.43 %
Crystal growTemperature: 295 K / Method: microbatch / pH: 7 / Details: 100mM Tris (7.0), 10% PEG 8000 200mM MgCl2

-
Data collection

DiffractionMean temperature: 100 K / Serial crystal experiment: N
Diffraction sourceSource: SYNCHROTRON / Site: ALS / Beamline: 8.3.1 / Wavelength: 1 Å
DetectorType: DECTRIS PILATUS3 S 6M / Detector: PIXEL / Date: Dec 15, 2017
RadiationProtocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray
Radiation wavelengthWavelength: 1 Å / Relative weight: 1
ReflectionResolution: 3.19→92.68 Å / Num. obs: 13821 / % possible obs: 99.9 % / Redundancy: 5.9 % / CC1/2: 0.99 / Rmerge(I) obs: 0.167 / Rpim(I) all: 0.08 / Net I/σ(I): 9.2
Reflection shellResolution: 3.19→3.41 Å / Redundancy: 5.8 % / Mean I/σ(I) obs: 2.1 / Num. unique obs: 2439 / CC1/2: 0.75 / Rpim(I) all: 0.406 / Rsym value: 0.837 / % possible all: 99.8

-
Processing

Software
NameVersionClassification
PHENIX(1.15.2_3472: ???)refinement
iMOSFLMdata reduction
Aimlessdata scaling
PHASERphasing
RefinementMethod to determine structure: MOLECULAR REPLACEMENT
Starting model: 2W96

2w96


Resolution: 3.19→44.698 Å / SU ML: 0.43 / Cross valid method: FREE R-VALUE / σ(F): 1.35 / Phase error: 27.1 / Stereochemistry target values: ML
RfactorNum. reflection% reflection
Rfree0.2575 721 5.24 %
Rwork0.2056 --
obs0.2084 13772 99.84 %
Solvent computationShrinkage radii: 0.9 Å / VDW probe radii: 1.11 Å / Solvent model: FLAT BULK SOLVENT MODEL
Refinement stepCycle: LAST / Resolution: 3.19→44.698 Å
ProteinNucleic acidLigandSolventTotal
Num. atoms4388 0 0 0 4388
Refine LS restraints
Refine-IDTypeDev idealNumber
X-RAY DIFFRACTIONf_bond_d0.0024477
X-RAY DIFFRACTIONf_angle_d0.4926062
X-RAY DIFFRACTIONf_dihedral_angle_d7.922761
X-RAY DIFFRACTIONf_chiral_restr0.037687
X-RAY DIFFRACTIONf_plane_restr0.004787
LS refinement shell
Resolution (Å)Rfactor RfreeNum. reflection RfreeRfactor RworkNum. reflection RworkRefine-ID% reflection obs (%)
3.1902-3.43650.35071340.28682544X-RAY DIFFRACTION100
3.4365-3.78210.27051390.22742568X-RAY DIFFRACTION100
3.7821-4.3290.28181310.20012591X-RAY DIFFRACTION100
4.329-5.45260.25251480.18472613X-RAY DIFFRACTION100
5.4526-44.70260.21751690.18732735X-RAY DIFFRACTION100
Refinement TLS params.

Method: refined / Refine-ID: X-RAY DIFFRACTION

IDL11 (°2)L12 (°2)L13 (°2)L22 (°2)L23 (°2)L33 (°2)S11 (Å °)S12 (Å °)S13 (Å °)S21 (Å °)S22 (Å °)S23 (Å °)S31 (Å °)S32 (Å °)S33 (Å °)T11 (Å2)T12 (Å2)T13 (Å2)T22 (Å2)T23 (Å2)T33 (Å2)Origin x (Å)Origin y (Å)Origin z (Å)
12.2054-0.0317-0.65644.0958-0.79194.18520.1922-0.05030.4364-0.06850.029-0.1504-0.4756-0.2248-0.20580.37360.01840.06080.3869-0.03720.43134.3608-13.3318-43.5482
25.20813.8424-2.55378.1149-0.84744.7082-0.03740.53440.0146-0.35750.08480.07880.0781-0.0991-0.01870.29490.0604-0.03690.52470.07430.357427.1216-31.8453-54.3308
35.03342.173-1.99962.7979-1.76852.55520.5824-0.45330.69420.5404-0.12290.4789-0.6511-0.4479-0.44480.59630.03090.11270.6499-0.1270.481317.2322-15.0266-20.7964
45.1444-0.31251.77347.546-2.23237.2320.3582-0.4214-0.32530.7957-0.1627-0.30150.4268-0.2723-0.16780.6045-0.0123-0.10780.6518-0.03410.361615.8516-36.5557-10.6482
51.62220.58950.89186.97662.36712.7670.1249-0.18520.3022-0.92190.9051-0.7065-0.61680.9834-0.7340.6643-0.13010.43171.19950.14920.983549.6064-8.0391-50.9608
60.95950.4958-0.67160.4918-1.00482.29930.0439-0.39941.10430.82150.0336-0.057-0.9799-0.1920.13391.33740.07930.2960.583-0.20771.563326.88365.1752-28.7069
Refinement TLS group
IDRefine-IDRefine TLS-IDSelection detailsAuth asym-IDAuth seq-ID
1X-RAY DIFFRACTION1( CHAIN A AND RESID 19:156 )A19 - 156
2X-RAY DIFFRACTION2( CHAIN A AND RESID 157:262 )A157 - 262
3X-RAY DIFFRACTION3( CHAIN B AND RESID 18:153 )B18 - 153
4X-RAY DIFFRACTION4( CHAIN B AND RESID 154:295 )B154 - 295
5X-RAY DIFFRACTION5( CHAIN C AND RESID 14:15 )C14 - 15
6X-RAY DIFFRACTION6( CHAIN C AND RESID 16:56 )C16 - 56

+
About Yorodumi

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242)：Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi

Thousand views of thousand structures

  • Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
  • This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
  • The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.

Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi

Read more